Therapeutic starvation and autophagy in prostate cancer: A new paradigm for targeting metabolism in cancer therapy

Prostate

Volumn 68, Issue 16, 2008, Pages 1743-1752

  DiPaola, Robert S ^a,b   Dvorzhinski, Dmitri ^b   Thalasila, Anu ^b   Garikapaty, Venkata ^b   Doram, Donyell ^b   May, Michael ^b   Bray, K ^c   Mathew, Robin ^c   Beaudoin, Brian ^c   Karp, C ^c   Stein, Mark ^a,b   Foran, David J ^b   White, Eileen ^b,c  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

Autophagy; Beclin1; Deoxyglucose; Glycolysis; Metabolism; Prostate cancer

Indexed keywords

BECLIN 1; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; DEOXYGLUCOSE; ENHANCED GREEN FLUORESCENT PROTEIN; LC3 PROTEIN; PROTEIN; UNCLASSIFIED DRUG; ANTIMETABOLITE; APOPTOSIS REGULATORY PROTEIN; BECN1 PROTEIN, HUMAN; CASPASE; LIGHT CHAIN 3, HUMAN; MEMBRANE PROTEIN; MICROTUBULE ASSOCIATED PROTEIN;

ARTICLE; AUTOPHAGY; CANCER THERAPY; CELL STRAIN LNCAP; CONTROLLED STUDY; CYTOTOXICITY; DIGITAL IMAGING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; STAINING; WESTERN BLOTTING; ADENOCARCINOMA; ALGORITHM; BIOLOGICAL MODEL; DIET THERAPY; DRUG EFFECT; METHODOLOGY; PHYSIOLOGY; PROSTATE TUMOR; STARVATION; TUMOR CELL LINE;

ADENOCARCINOMA; ALGORITHMS; ANTIMETABOLITES; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; CASPASES; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE 6; DEOXYGLUCOSE; HUMANS; MALE; MEMBRANE PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; MODELS, BIOLOGICAL; NUTRITION THERAPY; PROSTATIC NEOPLASMS; STARVATION;

EID: 56049108345     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.20837     Document Type: Article

References (18)

1. Petrylak DP. Future directions in the treatment of androgen-independent prostate cancer. Urology 2005;65:8-12.
2. DiPaola RS, Patel J, Rafi MM. Targeting apoptosis in prostate cancer. Hematol Oncol Clin North Am 2001;15(3):509-524.
3. Weinhouse S. The, Warburg hypothesis fifty years later. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol 1976;87(2):115-126.
4. Deberardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation. Cell metabolism 2008;7(1):11-20.
5. Dvorzhinski D, Thalasila A, Thomas PE, Nelson D, Li H, White E, DiPaola RS. A novel proteomic coculture model of prostate cancer cell growth. Proteomics 2004;4(10):3268-3275.
6. Liu H, Savaraj N, Priebe W, Lampidis TJ. Hypoxia increases tumor cell sensitivity to glycolytic inhibitors: A strategy for solid tumor therapy (Model C). Biochem Pharmacol 2002;64(12):1745-1751.
7. Munoz-Pinedo C, Ruiz-Ruiz C, Ruiz de Almodovar C, Palacios C, Lopez-Rivas A. Inhibition of glucose metabolism sensitizes tumor cells to death receptor-triggered apoptosis through enhancement of death-inducing signaling complex formation and apical procaspase-8 processing. J Biol Chem 2003;278(15):12759-12768.
8. Aft RL, Lewis JS, Zhang F, Kim J, Welch MJ. Enhancing targeted radiotherapy by copper(II)diacetyl- bis(N4-methylthiosemicarbazone) using 2-deoxy-D-glucose. Cancer Res 2003;63(17):5496-5504.
9. Kurtoglu M, Gao N, Shang J, Maher JC, Lehrman MA, Wangpaichitr M, Savaraj N, Lane AN, Lampidis TJ. Under normoxia, 2-deoxy-D-glucose elicits cell death in select tumor types not by inhibition of glycolysis but by interfering with N-linked glycosylation. Mol Cancer Ther 2007;6:3049-3058.
10. Jin S, DiPaola RS, Mathew R, White E. Metabolic catastrophe as a means to cancer cell death. J Cell Sci 2007;120(Pt 3):379-383.
11. Mathew R, Karantza-Wadsworth V, White E. Role of autophagy in cancer. Nat Rev Cancer 2007;7(12):961-967.
12. Amaravadi RK, Yu D, Lum JJ, Bui T, Christophorou MA, Evan GI, Thomas-Tikhonenko A, Thompson CB. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest 2007;117:326-336.
13. Ioffe ML, White E, Nelson DA, Dvorzhinski D, DiPaola RS. Epothilone induced cytotoxicity is dependent on p53 status in prostate cells. Prostate 2004;61(3):243-247.
14. Degenhardt K, Mathew R, Beaudoin B, Bray K, Anderson D, Chen G, Mukherjee C, Shi Y, Gelinas C, Fan Y, Nelson DA, Jin S, White E. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 2006;10:51-64.
15. Chen W, Reiss M, Foran DJ. A prototype for unsupervised analysis of tissue microarrays for cancer research and diagnostics. IEEE Trans Inf Technol Biomed 2004;8(2):89-96.
16. Karantza-Wadsworth V, Patel S, Kravchuk O, Cheng G, Mathew R, Jin S, White E. Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. Genes Dev 2007;21(13):1621-1635.
17. Aita VM, Liang XH, Murty VV, Pincus DL, Yu W, Cayanis E, Kalachikov S, Gilliam TC, Levine B. Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21. Genomics 1999;59:59-65.
18. Amaravadi RK, Thompson CB. The roles of therapy-induced autophagy and necrosis in cancer treatment. Clin Cancer Res 2007;13(24):7271-7279.